Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib-Reference-Cited by-同舟云学术

Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib

Published:2009-12 Issue:12 Volume:50 Page:2017-2029
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dumka Disha¹,Puri Poonam¹,Carayol Nathalie²³⁴,Lumby Crystal¹,Balachandran Harikrishnan¹,Schuster Katja¹,Verma Amit K.⁵,Terada Lance S.¹,Platanias Leonidas C.²³⁴,Parmar Simrit¹

Affiliation:

1. Dallas VAMedical Center and UT Southwestern Medical Center, Dallas, TX, USA

2. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, IL, USA

3. Division of Hematology–Oncology, Northwestern University Medical School, Chicago, IL, USA

4. Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA

5. Albert Einstein College of Medicine, Bronx, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428190903147637

Reference48 articles.

1. New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance

2. Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

3. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells

4. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies;iScience;2024-06

2. Resistance of prostate cancer to kinase inhibitors;Therapy Resistance in Prostate Cancer;2024

3. Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?;Expert Review of Anticancer Therapy;2022-11-24

4. Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies;2022-09-26

5. Small molecule photocatalysis enables drug target identification via energy transfer;Proceedings of the National Academy of Sciences;2022-08-15